Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 994


Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis.

Graham DY.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1117-1118. doi: 10.1111/apt.14339. No abstract available.


Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection.

Nell S, Estibariz I, Krebes J, Bunk B, Graham DY, Overmann J, Song Y, Spröer C, Yang I, Wex T, Korlach J, Malfertheiner P, Suerbaum S.

Gastroenterology. 2017 Oct 21. pii: S0016-5085(17)36273-X. doi: 10.1053/j.gastro.2017.10.014. [Epub ahead of print]


The Consensus from the Mycobacterium avium ssp. paratuberculosis (MAP) Conference 2017.

Kuenstner JT, Naser S, Chamberlin W, Borody T, Graham DY, McNees A, Hermon-Taylor J, Hermon-Taylor A, Dow CT, Thayer W, Biesecker J, Collins MT, Sechi LA, Singh SV, Zhang P, Shafran I, Weg S, Telega G, Rothstein R, Oken H, Schimpff S, Bach H, Bull T, Grant I, Ellingson J, Dahmen H, Lipton J, Gupta S, Chaubey K, Singh M, Agarwal P, Kumar A, Misri J, Sohal J, Dhama K, Hemati Z, Davis W, Hier M, Aitken J, Pierce E, Parrish N, Goldberg N, Kali M, Bendre S, Agrawal G, Baldassano R, Linn P, Sweeney RW, Fecteau M, Hofstaedter C, Potula R, Timofeeva O, Geier S, John K, Zayanni N, Malaty HM, Kahlenborn C, Kravitz A, Bulfon A, Daskalopoulos G, Mitchell H, Neilan B, Timms V, Cossu D, Mameli G, Angermeier P, Jelic T, Goethe R, Juste RA, Kuenstner L.

Front Public Health. 2017 Sep 27;5:208. doi: 10.3389/fpubh.2017.00208. eCollection 2017.


Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial.

Ruschitzka F, Borer JS, Krum H, Flammer AJ, Yeomans ND, Libby P, Lüscher TF, Solomon DH, Husni ME, Graham DY, Davey DA, Wisniewski LM, Menon V, Fayyad R, Beckerman B, Iorga D, Lincoff AM, Nissen SE; PRECISION-ABPM Investigators.

Eur Heart J. 2017 Aug 28. doi: 10.1093/eurheartj/ehx508. [Epub ahead of print]


Interchageable Use of Proton Pump Inhibitors Based on Relative Potency.

Graham DY, Tansel A.

Clin Gastroenterol Hepatol. 2017 Sep 28. pii: S1542-3565(17)31168-0. doi: 10.1016/j.cgh.2017.09.033. [Epub ahead of print]


Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?

Graham DY, Lu H, Shiotani A.

Saudi J Gastroenterol. 2017 Sep-Oct;23(5):265-267. doi: 10.4103/sjg.SJG_292_17. No abstract available.


Illusions regarding Helicobacter pylori clinical trials and treatment guidelines.

Graham DY.

Gut. 2017 Dec;66(12):2043-2046. doi: 10.1136/gutjnl-2017-314744. Epub 2017 Sep 21. No abstract available.


Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori.

Hu Y, Wan JH, Li XY, Zhu Y, Graham DY, Lu NH.

Aliment Pharmacol Ther. 2017 Nov;46(9):773-779. doi: 10.1111/apt.14319. Epub 2017 Sep 11. Review.


Empiric H. pylori therapy-10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best.

Yamaoka Y, Graham DY.

Transl Cancer Res. 2016 Dec;5(Suppl 7):S1476-S1478. doi: 10.21037/tcr.2016.12.39. No abstract available.


Interleukin-17C in Human Helicobacter pylori Gastritis.

Tanaka S, Nagashima H, Cruz M, Uchida T, Uotani T, Jiménez Abreu JA, Mahachai V, Vilaichone RK, Ratanachu-Ek T, Tshering L, Graham DY, Yamaoka Y.

Infect Immun. 2017 Sep 20;85(10). pii: e00389-17. doi: 10.1128/IAI.00389-17. Print 2017 Oct.


Changing Trends in Stomach Cancer Throughout the World.

Balakrishnan M, George R, Sharma A, Graham DY.

Curr Gastroenterol Rep. 2017 Aug;19(8):36. doi: 10.1007/s11894-017-0575-8. Review.


In Vivo Analysis of the Viable Microbiota and Helicobacter pylori Transcriptome in Gastric Infection and Early Stages of Carcinogenesis.

Thorell K, Bengtsson-Palme J, Liu OH, Palacios Gonzales RV, Nookaew I, Rabeneck L, Paszat L, Graham DY, Nielsen J, Lundin SB, Sjöling Å.

Infect Immun. 2017 Sep 20;85(10). pii: e00031-17. doi: 10.1128/IAI.00031-17. Print 2017 Oct.


Helicobacter pylori vacuolating cytotoxin and gastric cancer risk: reconsidered.

Miftahussurur M, Yamaoka Y, Graham DY.

Transl Cancer Res. 2016 Sep;5(Suppl 3):S557-S560. doi: 10.21037/tcr.2016.09.33. No abstract available.


Helicobacter, Hygiene, Atopy, and Asthma.

Miftahussurur M, Nusi IA, Graham DY, Yamaoka Y.

Front Microbiol. 2017 Jun 8;8:1034. doi: 10.3389/fmicb.2017.01034. eCollection 2017. Review.


It is time to rethink H. pylori therapy.

Dang BN, Graham DY.

J Gastrointestin Liver Dis. 2017 Jun;26(2):115-117. doi: 10.15403/jgld.2014.1121.262.hpy. No abstract available.


Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran.

Mohammadi M, Attaran B, Malekzadeh R, Graham DY.

Dig Dis Sci. 2017 Aug;62(8):1890-1896. doi: 10.1007/s10620-017-4628-5. Epub 2017 Jun 2. Review.


Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinoma.

Royse KE, Chen L, Berger DH, Ittmann MM, El-Serag HB, Balentine CJ, Graham DY, Richardson PA, Rumbaut RE, Shen X, White DL, Jiao L.

Int J Mol Epidemiol Genet. 2017 Apr 15;8(2):8-18. eCollection 2017.


Gastric Cancer as Preventable Disease.

Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, Graham DY.

Clin Gastroenterol Hepatol. 2017 May 19. pii: S1542-3565(17)30602-X. doi: 10.1016/j.cgh.2017.05.023. [Epub ahead of print]


Helicobacter pylori infection and antibiotic resistance: a WHO high priority?

Dang BN, Graham DY.

Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):383-384. doi: 10.1038/nrgastro.2017.57. Epub 2017 May 3. No abstract available.


Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.

Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, Chan FKL, Sung JJY, Kaplan GG, Ng SC.

Gastroenterology. 2017 Aug;153(2):420-429. doi: 10.1053/j.gastro.2017.04.022. Epub 2017 Apr 27. Review.

Supplemental Content

Loading ...
Support Center